404 related articles for article (PubMed ID: 15498633)
1. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer.
Varghese P; Mostafa A; Abdel-Rahman AT; Akberali S; Gattuso J; Canizales A; Wells CA; Carpenter R
Eur J Surg Oncol; 2007 Mar; 33(2):147-52. PubMed ID: 17081723
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
6. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
8. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
9. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients.
Canavese G; Gipponi M; Catturich A; Vecchio C; Tomei D; Nicoló G; Carli F; Spina B; Bonelli L; Villa G; Buffoni F; Bianchi P; Agnese A; Mariani G
J Surg Oncol; 2001 Jun; 77(2):81-7; discussion 88. PubMed ID: 11398158
[TBL] [Abstract][Full Text] [Related]
10. A further validation of subareolar injection technique for breast sentinel lymph node biopsy.
D'Eredita G; Giardina C; Guerrieri AM; Berardi T
Ann Surg Oncol; 2006 May; 13(5):701-7. PubMed ID: 16523366
[TBL] [Abstract][Full Text] [Related]
11. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
[TBL] [Abstract][Full Text] [Related]
12. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
[TBL] [Abstract][Full Text] [Related]
13. [Subareolar injection for sentinel lymph node biopsy in multiple breast cancer].
D'Eredità G; Troilo VL; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
G Chir; 2006; 27(11-12):436-41. PubMed ID: 17198554
[TBL] [Abstract][Full Text] [Related]
14. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement.
de Kanter AY; Menke-Pluijmers MB; Henzen-Logmans SC; van Geel AN; van Eijck CJ; Wiggers T; Eggermont AM
Eur J Surg Oncol; 2006 Jun; 32(5):498-501. PubMed ID: 16580810
[TBL] [Abstract][Full Text] [Related]
15. [lymphatic Mapping and Sentinel Lymph Node Biopsy in patients with Breast Cancer ].
Gallegos-Hernández JF; Chávez-García MA; Nájera I; Ramírez-Ramírez L; Durán-Martínez M
Gac Med Mex; 2003; 139(3):205-8. PubMed ID: 12872412
[TBL] [Abstract][Full Text] [Related]
16. [Validation protocol of sentinel node biopsy for breast cancer using radioactive tracer at the Institute of Oncology Bucharest "Prof. Dr. Alexandru Trestioreanu"].
Blidaru A; Bordea C; Voinea S; Condrea I; Albert P; Houcheimi B
Chirurgia (Bucur); 2006; 101(4):391-9. PubMed ID: 17059150
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.
Kern KA
J Am Coll Surg; 1999 Dec; 189(6):539-45. PubMed ID: 10589589
[TBL] [Abstract][Full Text] [Related]
18. Localization of the sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye and intraoperative gamma probe.
Villa G; Gipponi M; Buffoni F; Vecchio C; Bianchi P; Agnese G; Di Somma C; Catturich A; Rosato F; Tomei D; Nicolò G; Badellino F; Mariani G; Canavese G
Tumori; 2000; 86(4):297-9. PubMed ID: 11016707
[TBL] [Abstract][Full Text] [Related]
19. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
Allen B; Campbell I; Desai S; Dray M; Scarlet J
N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
[TBL] [Abstract][Full Text] [Related]
20. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]